AstraZeneca's earnings top estimates but shares fall on core operating profit drop
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
AstraZeneca Full year and Q4 2023 Financial Results
February 8, 2024 2:04 AM ESTStrong growth and pipeline momentum with three new medicines approved since the third quarter
CAMBRIDGE, United Kingdom--(BUSINESS WIRE)-- AstraZeneca:
Revenue and EPS summary
Â
Â
FY 2023
Q4 2023
Â
Â
Â
%... More
